ABT-702

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameABT-702
Drug Alias NameABT-702
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine kinase inhibitors
TargetsAdenosine kinase
Therapy Area/IndicationsPainArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAbbott Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbbott Laboratories
Active IndicationsN/A
Inactive IndicationsPainArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A